Clinical Trial

The Efficacy of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease:A Randomized, Double-blind, Multicenter, Placebo-controlled Trial

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive and widely used neuromodulation technology. Small sample studies have shown that rTMS treatment can significantly improve the symptoms of Parkinson's disease(PD) and delay the progression of the disease. In order to further explore the effectiveness of rTMS in the treatment of PD and lay the foundation for its clinical promotion, our research team plans to conduct a randomized double-blind controlled study of rTMS in the treatment of PD in multiple centers across the country.
Trial Details
NCT Number NCT06583278
Lead Sponsor Anhui Medical University
Conditions Parkinson Disease, Transcranial Magenetic Stimualtion, Supplementary Motor Area
Enrollment 312 participants
Start Date 2024-11-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-09-04